Global ROS1 initiative: A patient-researcher collaboration targeting ROS1 cancer
Cancer patients have often organised support and informational groups around their disease types. Now a…
Browsing: AACR 2018
AACR 2018: Sedentary lifestyle drastically increases risk of dying from cancer
Researchers from Roswell Park Comprehensive Cancer contribute to the growing body of evidence linking physical…
AACR 2018: Strategies identified to reverse obesity’s lingering, pro-cancer effects
Like exposure to too much sun and drinking alcohol, obesity is a risk factor for…
AACR 2018: Researchers identify epigenetic changes that may help explain racial disparities in breast cancer
As culture shapes our environment, which in turn influences how genes are expressed, cultural differences…
AACR 2018: How do melanoma cells survive drug treatment long enough to acquire drug resistance?
Cancer often picks up genetic changes that allow it to resist treatment. But this takes…
AACR 2018: Effect of prostate cancer gene can go either way
Roswell Park Comprehensive Cancer Center researchers have found that the effect of a key gene…
AACR 2018: An off-the-shelf, dual-targeted CAR T-cell product showed promising results in preclinical studies
FT819, an off-the-shelf, T-cell receptor (TCR)-less CD19 CAR T-cell product that could potentially be made…
AACR 2018: Neoadjuvant nivolumab was safe, yielded pathologic responses in patients with resectable lung cancer
The anti-PD1 immunotherapy nivolumab given prior to surgical resection of stage 1-3 non-small cell lung…
AACR 2018: Combination therapy doubles survival in metastatic lung cancer
The immunotherapy drug pembrolizumab, when combined with chemotherapy, doubles survival in patients with non-squamous non-small…
AACR 2018: Precancerous colon polyps in patients with Lynch syndrome exhibit immune activation
Colon polyps from patients with Lynch syndrome, a hereditary condition that raises colorectal cancer risk,…